Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study)

L. Borderias, G. Mincewicz, P. Paggiaro, M. Guilera, V. Sazonov Kocevar, X. Badia (Huesca, Barcelona, Spain; Gdask, Poland; Pisa, Italy; Whitehouse Station, United States Of America)

Source: Annual Congress 2005 - Monitoring response to treatment in asthma and COPD
Session: Monitoring response to treatment in asthma and COPD
Session type: Thematic Poster Session
Number: 3692
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Borderias, G. Mincewicz, P. Paggiaro, M. Guilera, V. Sazonov Kocevar, X. Badia (Huesca, Barcelona, Spain; Gdask, Poland; Pisa, Italy; Whitehouse Station, United States Of America). Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study). Eur Respir J 2005; 26: Suppl. 49, 3692

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Reduction in asthma-related costs following treatment with montelukast (PRAACTICAL study)
Source: Eur Respir J 2005; 26: Suppl. 49, 577s
Year: 2005

Effectiveness of pharmacist intervention for asthma control improvement
Source: Eur Respir J 2008; 31: 790-799
Year: 2008



Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Change of inhalation device: impact on asthma control and compliance in general practice. SYSTER survey
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015

Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012


Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study
Source: Eur Respir J 2007; 30: Suppl. 51, 34s
Year: 2007

Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009


Impact of a mobile health pilot study on asthma rescue inhaler use, control and self-management
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016

Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Achieving guideline-based asthma control: does the patient benefit?
Source: Eur Respir J 2002; 20: 588-596
Year: 2002



The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016